According to the official website of the China Drug Administration, Johnson & Johnson's Maxitentan dispersible tablets have been approved for marketing. It is speculated that the indication is pulmonary hypertension in children.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.